SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 26th, 2017 • BioPharmX Corp • Pharmaceutical preparations • New York
Contract Type FiledApril 26th, 2017 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of April 26, 2017, between BioPharmX Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
EXHIBIT A COMMON STOCK PURCHASE WARRANT biopharmx corporationBioPharmX Corp • April 26th, 2017 • Pharmaceutical preparations
Company FiledApril 26th, 2017 IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after October __, 2017 (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioPharmX Corporation, a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).